Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
ASSETS
Cash and cash equivalents	$ 259,701	$ 312,727
Grant funds and other receivables	121,814	59,758
Prepaid expenses and other current assets	238,189	75,589
Total current assets	619,704	448,074
Property and equipment, net (Note 3)	11,350	31,151
Deposits	11,010	11,010
Total assets	642,064	490,235
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIENCY)
Accounts payable	125,859	77,581
Accrued expenses (Note 4)	1,238,552	733,711
Current portion of notes payable (Note 5)	260,420
Total current liabilities	1,624,831	811,292
Note payable, net of current portion (Note 5)	39,580
Total liabilities	1,664,411	811,292
Commitments (Note 6)
Stockholders’ equity (deficiency):
Common stock, $.001 par value: Authorized shares – 600,000,000 Issued and outstanding shares – 218,903,476 and 106,736,810 at December 31, 2018 and 2017, respectively	218,903	106,737
Additional paid-in capital	37,264,301	35,589,911
Accumulated deficit	(40,476,884)	(37,916,790)
Total stockholders’ equity (deficiency)	(1,022,347)	(321,057)
Total liabilities and stockholders’ equity (deficiency)	642,064	490,235
Series B Convertible Preferred Stock [Member]
Stockholders’ equity (deficiency):
Convertible Preferred Stock	76,095	76,095
Series C Convertible Preferred Stock [Member]
Stockholders’ equity (deficiency):
Convertible Preferred Stock	705,238	842,990
Series D Convertible Preferred Stock [Member]
Stockholders’ equity (deficiency):
Convertible Preferred Stock		980,000
Series E Convertible Preferred Stock [Member]
Stockholders’ equity (deficiency):
Convertible Preferred Stock	$ 1,190,000